TO ALL ENLISTED : METFORMIN ISN'T THE BEST DRUG FOR DIABETES MELLITUS, TYPE TWO NOW :
https://www.cnn.com/2022/03/28/health/paternal-metformin-use-birth-defects/index.html
BETTER ALTERNATIVES :
JARDIANCE, ESPECIALLY IF HEART ATTACKS, KIDNEY DAMAGE ARE A HIGHER RISK FOR THE PATIENT
FARXIGA IS BEST FOR PATIENTS AT RISK FOR HEART FAILURE
LINAGLIPTON IS MORE CONVENIENT FOR THE PATIENT OVER METFORMIN
SEMAGLUTIDE SHOULD BE CONSIDERED FOR OBESITY, AND MILD OBESITY PATIENTS
GLICAZIDE INCREASES THE INSULIN PRODUCED IN THE PANCREAS, BUT CAN CAUSE HYPOGLYCEMIA
VICTOZA, IN NEWER, WEEKLY FORMS, TO PREVENT G.I. TRACT SIDE EFFECTS, IS GREAT FOR COMORBID OBESITY, WITH TYPE TWO DIABETES MELLITUS, AS IT AIDS IN WEIGHT LOSS FOR PATIENTS
LANTUS
GLIPTINS
PIOGLITAZONE, UNFORTUNATELY, INCREASES BONE FRACTURE RISKS IN WOMEN, INCREASES HEART FAILURE IN ELDERLY, INCREASES RISK FOR REDUCED VISUAL ACUITY RELATED TO IMPAIRED ABILITY TO DISTINGUISH BETWEEN SHAPES, FROM WORSENING DIABETIC MACULAR EDEMA, INCREASES LIVER DYSFUNCTION RISKS, AND ELEVATES BLADDER CANCER RISK, SO AVOID IT NOWADAYS
***BRING ALL TYPE TWO DIABETES MELLITUS PATIENTS TO THREE TIMES PER DAY, OF DAILY INSULIN, ECMO, AND NON-ECMO DIALYSIS CLINICS TOO.***
***REMEMBER, WITHIN A YEAR OF COVID-19 INFECTION, ESPECIALLY A SEVERE ONE, THE RISK FOR DIABETES MELLITUS IS EXTREMELY HIGH TOO***
TO LOWER A1C LEVELS OF PATIENTS WITH GREATER THAN 7% A1C :
LIRAGLUTIDE, INSULIN GLARGINE :
**************************
IN THE JESUS COURT, CURRENTLY :
A DEBATE IS GOING ON, ABOUT THE CROSS OF CONFUSION :
THE CROSS OF CONFUSION CONTROVERSY :
https://boards.straightdope.com/t/the-so-called-cross-of-confusion/131014/6
FAVE :
TRY TO GET THE ENLISTED INTO WEARING MORE ACCESSORIES :
THERE ARE $2 BARGAIN JEWELRY SETS THERE.
Comments
Post a Comment